Cencora, Inc. COR

306.92 (2.95) (0.95%) as of 25 Sep
Market cap
$59.1B
P/E
22.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Cencora, Inc. (COR) EV/Sales

As of 25 September 2026, Cencora, Inc. (COR) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from 0.1× (March 2020) to 0.2× (March 2026); the current reading is higher than 92% of that period. That is below the Medical Distribution industry median of 0.6× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 0.2× 27.19%
FY2024 0.2× 6.54%
FY2023 0.1× 14.70%
FY2022 0.1× (4.77%)
FY2021 0.1× 31.67%
FY2020 0.1× (0.58%)
FY2019 0.1× (23.03%)
FY2018 0.1× 4.39%
FY2017 0.1× (0.62%)
FY2016 0.1× (21.55%)

Quarterly

Period EV/Sales Change
Jun 2026 0.2× (11.98%)
Mar 2026 0.2× (1.50%)
Dec 2025 0.2× 10.81%
Sep 2025 0.2× (1.83%)
42 more quarters

Against its own ten years

Low 0.1× High 0.2×
Ten-year median 0.1×
Current reading's percentile 92

EV/Sales against peers

Company EV/Sales
YI 111, Inc. Sponsored ADR compare 0.0×
COR Cencora, Inc. 0.2×
CAH Cardinal Health, Inc. compare 0.2×
MCK McKesson Corporation compare 0.3×
COSM Cosmos Health Inc. compare 0.4×
ACH Accendra Health, Inc. compare 0.9×
HSIC Henry Schein, Inc. compare 0.9×
AHG Akso Health Group Sponsored ADR compare 1.5×
FOCL FocalTherics compare 2.4×
Medical Distribution industry median 0.6×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on COR